Aspirin Chewable tablet 81 mg
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Subpotent Drug: Product failed to meet USP Specifications on assay, content uniformity, and dissolution.
Cause type: Wrong potency / content
Sub- or super-potent product, or a failed content-uniformity / assay test. You may receive too little or too much active ingredient - a direct dosing risk. All wrong potency / content recalls.
Assured Aspirin Enteric Safety Coated Tablets, 81 mg, Adult Low Strength, Pain Reliever (NSAID), 60-count bottle, Distributed by Greenbrier International, Inc., Chesapeake, VA 23320 UPC 639277018328.
Drug: Aspirin Category: Pain Relief & OTC Medication
Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
cGMP Deviations: Observations were made that some blister card-foils were separating from the blister cavity.
Labeling: Missing Label - some bottles are missing the the manufacturers label that includes the drug facts information.
Failed Tablet/Capsule Specification : Capsule breakage
CGMP Deviations: product held outside appropriate storage temperature conditions.
CGMP Deviations
Subpotent Drug
Subpotent Drug: Heparin raw material was found to have low potency
Subpotent; 6 month stability time point
Subpotency: Out of Specification (OOS) result at the 36 month routine stability time point.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.